Targeted delivery of antigens and CpG oligonucleotides to intracellular TLR9 receptors

被引：0
|
作者：
Salem, Aliasger K. [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2010年 / 239卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
105-BIOT
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9
    Avalos, Ana M.
    Ploegh, Hidde L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (10) : 2820 - 2827
  • [2] CpG oligonucleotides bind TLR9 and RRM-Containing proteins in Atlantic Salmon (Salmo salar)
    Dimitar B Iliev
    Ingrid Skjæveland
    Jorunn B Jørgensen
    BMC Immunology, 14
  • [3] Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9
    Liu, Jin
    Xu, Congfeng
    Liu, Yi-Ling
    Matsuo, Hanako
    Hsieh, Rebecca Pe-Feng
    Lo, Jeng-Fan
    Tseng, Ping-Hui
    Yuan, Chiun-Jye
    Luo, Yunping
    Xiang, Rong
    Chuang, Tsung-Hsien
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2012, 35 (05) : 443 - 451
  • [4] CpG oligonucleotides bind TLR9 and RRM-Containing proteins in Atlantic Salmon (Salmo salar)
    Iliev, Dimitar B.
    Skjaeveland, Ingrid
    Jorgensen, Jorunn B.
    BMC IMMUNOLOGY, 2013, 14
  • [5] Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
    Vollmer, Joerg
    Krieg, Arthur M.
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (03) : 195 - 204
  • [6] Distribution of TLR9 and uptake of CpG in human neutrophils
    Hedrick, TL
    Smith, RL
    King, CS
    McElearney, ST
    Saalwachter, AR
    Rudy, CK
    Du, KP
    Pruett, TL
    Sawyer, RG
    FASEB JOURNAL, 2005, 19 (04): : A373 - A373
  • [7] CpG Oligodeoxynucleotides as TLR9 AgonistsTherapeutic Applications in Cancer
    Yanal M. Murad
    Timothy M. Clay
    BioDrugs, 2009, 23 : 361 - 375
  • [8] Bacterial CpG-DNA licenses TLR9
    Bauer, S
    Wagner, H
    TOLL-LIKE RECEPTOR FAMILY MEMBERS AND THEIR LIGANDS, 2002, 270 : 145 - 154
  • [9] Phase lb trial of a targeted TLR9 CpG immunomodulator (CPG 7909) in advanced renal cell carcinoma (RCC).
    Thompson, JA
    Kuzel, T
    Bukowski, R
    Masciari, F
    Schmalbach, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 417S - 417S
  • [10] Introduction of sugar-modified nucleotides into CpG-containing antisense oligonucleotides inhibits TLR9 activation
    Yoshida, Tokuyuki
    Hagihara, Tomoko
    Uchida, Yasunori
    Horiuchi, Yoshiyuki
    Sasaki, Kiyomi
    Yamamoto, Takenori
    Yamashita, Takuma
    Goda, Yukihiro
    Saito, Yoshiro
    Yamaguchi, Takao
    Obika, Satoshi
    Yamamoto, Seiji
    Inoue, Takao
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345